GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Recruiting · NCT07221214 · Registry updated 2026-05-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV | cardiovascular disorder | Recruiting | Phase 2 | 2026-05-26 | NCT07221214 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 228 |
| Norton Healthcare | 5 |
| University of Louisville | 62 |
| Vanderbilt University Medical Center | 299 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | United States | 427 |